Silo Pharma, Inc. cotiza a 1.13 USD y tiene una capitalización bursátil de $2M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing …
| Periodo | 2024-03 | 2023-11 |
|---|---|---|
| Real | $-5.40 | $-3.15 |
| Estimado | $-3.00 | $-4.65 |
| Sorpresa | -80.0% | +32.3% |
| Métrica | SILO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 38.6% | 57.0% | -18.5% |
| Operating Margin | -5936.9% | -38.6% | -5898.3% |
| Net Margin | -5863.5% | -33.6% | -5829.9% |
| FCF Margin | — | -13.9% | — |
| ROE | -67.0% | -40.4% | -26.6% |
| ROA | -55.6% | -32.0% | -23.6% |
| Current Ratio | 11.36 | 2.84 | +8.52 |
| Debt / Equity | — | 0.28 | — |